Search research articles
Contact Us
Filters
Showing results (21-30 of 85) with videos related to
Page
of 9
Sort By:
Haematologica
|
November 20, 2025
JAK inhibitor selection in challenging scenarios of myelofibrosis: a review
Pankit Vachhani, Ruben Mesa, John Mascarenhas, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)
|
May 26, 2018
Soluble B7-H4 blood serum levels are elevated in women at high risk for preeclampsia in the first trimester, as well as in patients with confirmed preeclampsia
Pawel Mach, Luisa Nolte-Boenigk, Leonie Droste, et al.
Leukemia
|
May 13, 2020
Posttransplant cyclophosphamide after allogeneic hematopoietic cell transplantation mitigates the immune activation induced by previous nivolumab therapy
Juan C Nieto, Elisa Roldán, Isabel Jiménez, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 15, 2019
Effect of Sirolimus Exposure on the Need for Preemptive Antiviral Therapy for Cytomeglovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation
Beatriz Guglieri-Lopez, Alejandro Perez-Pitarch, Irene Garcia-Cadenas, et al.
Journal of Medical Virology
|
July 5, 2023
Assessment of the potential value of plasma Torque Teno virus DNA load monitoring to predict cytomegalovirus DNAemia in patients with hematological malignancies treated with small molecule inhibitors: A proof-of-concept study
Carlos Solano de la Asunción, Estela Giménez, Juan Carlos Hernández-Boluda, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 12, 2017
A Time-to-Event Model for Acute Kidney Injury after Reduced-Intensity Conditioning Stem Cell Transplantation Using a Tacrolimus- and Sirolimus-based Graft-versus-Host Disease Prophylaxis
José Luis Piñana, Alejandro Perez-Pitarch, Irene Garcia-Cadenas, et al.
Ejhaem
|
February 26, 2024
Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosis
Stephen T Oh, Srdan Verstovsek, Vikas Gupta, et al.
Transfusion Medicine Reviews
|
March 26, 2018
Autoimmune hemolytic anemia (AIHA) following allogeneic hematopoietic stem cell transplantation (HSCT): A retrospective analysis and a proposal of treatment on behalf of the Grupo Español De Trasplante de Medula Osea en Niños (GETMON) and the Grupo Español de Trasplante Hematopoyetico (GETH)
Marta González-Vicent, Jaime Sanz, José Luis Fuster, et al.
Bone Marrow Transplantation
|
February 9, 2019
Author Correction: Donor lymphocyte infusions for B-cell malignancies relapse after T-cell replete allogeneic hematopoietic cell transplantation
Guillermo Ortí, Irene García-Cadenas, Lucia López-Corral, et al.
Hematological Oncology
|
March 18, 2026
Preliminary Safety and Efficacy of Navitoclax Plus Ruxolitinib in Janus Kinase Inhibitor-Naïve Patients With Myelofibrosis From the Multicenter, Open-Label, Phase 2 Study (REFINE)
Francesco Passamonti, James M Foran, Anand Tandra, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 85) with videos related to
Sort By:
Page
of 9
Haematologica
|
November 20, 2025
JAK inhibitor selection in challenging scenarios of myelofibrosis: a review
Pankit Vachhani, Ruben Mesa, John Mascarenhas, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)
|
May 26, 2018
Soluble B7-H4 blood serum levels are elevated in women at high risk for preeclampsia in the first trimester, as well as in patients with confirmed preeclampsia
Pawel Mach, Luisa Nolte-Boenigk, Leonie Droste, et al.
Leukemia
|
May 13, 2020
Posttransplant cyclophosphamide after allogeneic hematopoietic cell transplantation mitigates the immune activation induced by previous nivolumab therapy
Juan C Nieto, Elisa Roldán, Isabel Jiménez, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 15, 2019
Effect of Sirolimus Exposure on the Need for Preemptive Antiviral Therapy for Cytomeglovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation
Beatriz Guglieri-Lopez, Alejandro Perez-Pitarch, Irene Garcia-Cadenas, et al.
Journal of Medical Virology
|
July 5, 2023
Assessment of the potential value of plasma Torque Teno virus DNA load monitoring to predict cytomegalovirus DNAemia in patients with hematological malignancies treated with small molecule inhibitors: A proof-of-concept study
Carlos Solano de la Asunción, Estela Giménez, Juan Carlos Hernández-Boluda, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 12, 2017
A Time-to-Event Model for Acute Kidney Injury after Reduced-Intensity Conditioning Stem Cell Transplantation Using a Tacrolimus- and Sirolimus-based Graft-versus-Host Disease Prophylaxis
José Luis Piñana, Alejandro Perez-Pitarch, Irene Garcia-Cadenas, et al.
Ejhaem
|
February 26, 2024
Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosis
Stephen T Oh, Srdan Verstovsek, Vikas Gupta, et al.
Transfusion Medicine Reviews
|
March 26, 2018
Autoimmune hemolytic anemia (AIHA) following allogeneic hematopoietic stem cell transplantation (HSCT): A retrospective analysis and a proposal of treatment on behalf of the Grupo Español De Trasplante de Medula Osea en Niños (GETMON) and the Grupo Español de Trasplante Hematopoyetico (GETH)
Marta González-Vicent, Jaime Sanz, José Luis Fuster, et al.
Bone Marrow Transplantation
|
February 9, 2019
Author Correction: Donor lymphocyte infusions for B-cell malignancies relapse after T-cell replete allogeneic hematopoietic cell transplantation
Guillermo Ortí, Irene García-Cadenas, Lucia López-Corral, et al.
Hematological Oncology
|
March 18, 2026
Preliminary Safety and Efficacy of Navitoclax Plus Ruxolitinib in Janus Kinase Inhibitor-Naïve Patients With Myelofibrosis From the Multicenter, Open-Label, Phase 2 Study (REFINE)
Francesco Passamonti, James M Foran, Anand Tandra, et al.
Page
of 9